The main actions of TROP-2 include activating the mitogen-activated protein kinase (MAPK) pathway as well as the extracellular signal-related kinase (ERK) and c-Jun N-terminal kinase (JKN) pathway that induce tumor cell survival, proliferation, invasion, migration and metastasis [2]. Here, TACSTD2 is linked to neoplasm.